|1.||Inoue, K: 2 articles (10/2001 - 08/2001)|
|2.||Sugimoto, Y: 2 articles (10/2001 - 08/2001)|
|3.||Yamada, J: 2 articles (10/2001 - 08/2001)|
|4.||Ohkura, M: 2 articles (10/2001 - 08/2001)|
|5.||Hsieh, M T: 2 articles (01/2001 - 01/2000)|
|6.||Wu, C R: 2 articles (01/2001 - 01/2000)|
|7.||Ishiwata, Kiichi: 1 article (08/2011)|
|8.||Ramakrishnan, Nisha K: 1 article (08/2011)|
|9.||Luiten, Paul G M: 1 article (08/2011)|
|10.||Elsinga, Philip H: 1 article (08/2011)|
01/04/1996 - "Results from an ancillary control experiment indicated that the p-chloroamphetamine-induced passive avoidance impairment was not related to drug-induced alterations in pain sensitivity. "
04/01/1970 - "Prevention of pain-induced aggression by parachloroamphetamine."
01/01/1985 - "Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: dissociable serotoninergic involvement in avoidance learning, pain and motor function."
12/01/1995 - "The present study examined whether chronic pain parenchymal administration of the neurotrophins brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) or NGF could prevent the severe degenerative loss of serotonergic axons normally caused by the selective 5-HT neurotoxin p-chloroamphetamine (PCA). "
01/01/1980 - "The effects of the specific 5-HT uptake inhibitors alaproclate and zimelidine, the 5-HT releasing compound p-chloroamphetamine (PCA) and the specific NA uptake inhibitor desipramine on pain sensitivity were examined in male rats using the hot-plate and tail-flick methods. "
09/01/1982 - "For both 5.0 mg/kg and 10 mg/kg parachloroamphetamine dose levels, restraint-plus-shock generated the highest percent mortality, followed by restraint-only, with conspecific aggregation producing a mortality incidence lower still. "
01/01/1986 - "Conversely, acute treatment with a moderate dose of the 5-HT releasing agent p-chloroamphetamine (PCA) effectively antagonized the escape interference ordinarily provoked by inescapable shock. "
01/01/1986 - "Influence of p-chloroamphetamine and methysergide on the escape deficits provoked by inescapable shock."
08/07/1981 - "The acute effect of the 5-hydroxytryptamine (5-HT) releasing compound p-chloroamphetamine (PCA) on the acquisition and retention of shock-elicited fear conditioning to the contextual cues of a normal two-compartment shuttlebox in the rat was studied in three experiments. "
03/01/1975 - "p-Chloroamphetamine (PCA), a serotonin depletor, was given to rats at least 24 h prior to testing in an open field or a shock avoidance Y-maze task. "
|3.||Amnesia (Dissociative Amnesia)
08/11/1994 - "In addition, the ameliorating effect of (+)-SKF-10,047 against the p-chloroamphetamine-induced amnesia was superior to that of (-)-SKF-10,047. "
01/01/2001 - "The serotonin releaser, p -chloroamphetamine significantly antagonized the ameliorating effect of FS(w)on CXM-induced amnesia. "
02/01/2003 - "The ameliorating effects of LiuWei Dihuang Wang (LDW) after single, one-week or two-week treatment of scopolamine (SCOP)-induced and p-chloroamphetamine (PCA)-induced amnesia by using the passive avoidance task and the facilitatory effects on two-way active avoidance performance in rats were studied. "
01/01/2000 - "Radix Angelica Sinensis extracts ameliorate scopolamine- and cycloheximide-induced amnesia, but not p-chloroamphetamine-induced amnesia in rats."
08/11/1994 - "Three sigma receptor ligands were examined for their ameliorating effects on p-chloroamphetamine-induced amnesia in mice. "
|4.||Serotonin Syndrome (Syndrome, Serotonin)
02/26/1982 - "Intracellular recordings were made from facial motoneurons of anesthetized rats during systemic administration of 5-methoxy-N,-N-dimethyltryptamine (5-MeODMT) and p-chloroamphetamine (PCA), drugs which elicit the behavioral serotonin syndrome. "
12/01/1979 - "A frequency analysis of behavior components of the serotonin syndrome produced by p-chloroamphetamine."
08/01/2009 - "Altered postsynaptic-density-levels of caldendrin in the para-chloroamphetamine-induced serotonin syndrome but not in the rat ketamine model of psychosis."
10/24/1997 - "Drugs such as p-chloroamphetamine or a combination of tranylcypromine and tryptophan release serotonin in the central nervous system and produce a behavioral serotonin syndrome. "
11/01/1977 - "A single dose of p-chloroamphetamine, 10 mg per kilogram, produced postural abnormalities, tremor, myoclonus, and autonomic signs in rats 5 minutes after intraperitoneal injection. "
07/01/1986 - "The behavioural responses to 5-MeODMT (with and without the monoamine oxidase inhibitor pargyline) or to p-chloroamphetamine were not significantly different to those of males except for tremor after p-chloroamphetamine which was more marked in the females. "
03/25/1985 - "Some responses to the 5-HT releaser p-chloroamphetamine (PCA) (4 and 10 mg/kg, i.p.) and the 5-HT agonist 5-methoxy-N,N-dimethyltryptamine (5-MEODMT) (5 mg/kg, i.p.) (forepaw treading and tremor) were enhanced after 7 days immobilization but others (limb abduction and headweaving) were not. "
01/01/1991 - "Idazoxan pre-treatment, in rats, enhanced forepaw treading, head weaving and tremor induced by the 5-HT agonist 5-methoxy-N,N dimethyltryptamine (5-MeODMT), increased head twitches (but decreased hindlimb abduction) induced by the 5-HT releaser p- chloroamphetamine (pCA), but did not clearly alter head twitches induced by the 5-HT precursor L-5-hydroxytryptophan in mice. "
|1.||Serotonin (5 Hydroxytryptamine)
|2.||Nerve Growth Factor (NGF)
|3.||Brain-Derived Neurotrophic Factor (BDNF)
|4.||Nerve Growth Factors (Neurotrophins)
|9.||Serotonin Receptor Agonists (Serotonin Receptor Agonist)